Status:
UNKNOWN
Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
Lead Sponsor:
Azienda Ospedaliera Sant'Anna
Collaborating Sponsors:
Amgen
Conditions:
Hyperparathyroidism, Secondary
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Clinical study aimed at improving anemia management in End Stage Renal Disease Patient (ESRD) on maintenance Hemodialysis with evidence of Chronic Kidney disease Mineral Bone Disorder (CKD-MBD)
Detailed Description
Anemia is one of the most worrisome complications of Chronic Kidney Disease (CKD). Numerous prospective studies have repeatedly documented an increase risk of morbidity and mortality associated with l...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA.
- Men and women
- Age \>18 years
- Maintenance dialysis via Artero-Venous fistula
- ESA use
- iPTH between 300-600 pg/ml
- Hb between 10.0-11.5
- Kt/V greater/equal than 1.2
- Signed informed consent prior to the initiation of the study
- EXCLUSION CRITERIA: None.
Exclusion
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02273570
Start Date
March 1 2015
End Date
March 1 2017
Last Update
September 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Sant'Anna
San Fermo Della Battaglia (CO), Italy, 22020